HMGB1 is a well-characterized DAMP in the setting of stroke, where its in vivo neutralization results in decreased microglial activation, cytokine and iNOS expressions, and reduced permeability of the blood brain barrier [67, 68]. This evidence concerns the gene NOS2 and stroke disorder.